Avtozma
Avtozma Recall Summary Avtozma, a medication containing tocilizumab used to treat rheumatoid arthritis, juvenile rheumatoid arthritis, cytokine release syndrome, and COVID-19, has been recalled across the European Union due to a medication error and quality defect. This is a Class I recall, the most serious classification. The recall affects all patients in the EU who have this medication.
- Product
- Active substances: tocilizumab. Therapeutic area: Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection. ATC code: L04AC07
- Reason
- Medication error;Quality defect
- Classification
- Class I
- Category
- drug recall
- Country
- European Union
- Agency
- EMA-DHPC
- Recall date
- 2026-04-03
- Status
- Ongoing
- Distribution
- European Union
Official recall notice from EMA-DHPC
Recall details on Nibble Recalls: https://trynibble.app/recalls/95809236-0bc9-4440-8a1b-6c53fb4aff7e